| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Procter and Gamble |
| Information provided by: | Procter and Gamble |
| ClinicalTrials.gov Identifier: | NCT00071409 |
Purpose
Insulin is a chemical that the body needs in order to use or store sugar. It is made by a type of cell called a beta cell which resides in an organ known as the pancreas. Type 1 diabetes is a disease where the beta cells have been destroyed so that little or no insulin is made. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new beta cells in the pancreas, and to restore the ability to produce insulin in type 1 diabetic patients.
| Condition | Intervention | Phase |
|
Diabetes Mellitus, Insulin-Dependent |
Drug: INGAP-Peptide |
Phase II |
| MedlinePlus related topics: | Diabetes Diabetes Type 1 |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Eligibility
| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Contacts and Locations| United States, California | |||||
| Radiant Research | |||||
| Irvine, California, United States, 92618 | |||||
| Diablo Clinical Research | |||||
| Walnut Creek, California, United States, 94598 | |||||
| VA Hospital UCSD | |||||
| San Diego, California, United States, 92161 | |||||
| United States, District of Columbia | |||||
| MedStar Clinical Research Center | |||||
| Washington, District of Columbia, United States, 20003 | |||||
| United States, Illinois | |||||
| Springfield Diabetes and Endocrine Center | |||||
| Springfield, Illinois, United States, 62704 | |||||
| United States, Montana | |||||
| Mercury Street Medical | |||||
| Butte, Montana, United States, 59701 | |||||
| United States, North Carolina | |||||
| UNC Diabetes Care Center | |||||
| Durham, North Carolina, United States, 27713 | |||||
| United States, Oregon | |||||
| Clinical Research Institute of Southern Oregon | |||||
| Medford, Oregon, United States, 97504 | |||||
| United States, Texas | |||||
| DGD Research Associates | |||||
| San Antonio, Texas, United States, 78229 | |||||
| University of Texas Health Science Center - Texas Diabetes Institute | |||||
| San Antonio, Texas, United States, 78207 | |||||
| Procter and Gamble |
More Information
| Study ID Numbers: | 2003068 |
| First Received: | October 22, 2003 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00071409 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|
